Home
Finance
Bank Routing Numbers
FedWire
Stock Portfolio Generator
Technical Analysis of Stocks
Best Months to Buy or Sell Stocks
Games
Hangman - Hang 'Em High
Chess
Shuttles Game
Chemistry
Chemical Equation Balancer
Periodic Table of the Elements
Chemical Bond Polarity Calculator
Linear Algebra
Gauss-Jordan Elimination Calculator
Calculate Pivots
Factorize: A=LU
Inverse Matrix Calculator
Null Space Calculator
Column Space Calculator
Row Space Calculator
Multiply Two Matrices
AI
Genetic Algorithms
Genetic Algorithms Stock Portfolio Generator
Shuttles Game
Tic-Tac-Toe Game
Personality Profile
Checkers Game
Scripts
Scan for all machines running IIS in a domain
Extract data from a Microsoft Word document
Outlook Scripts
Excel Scripts
IT
How to Stop a DDOS Attack
Subnet Calculator
Fingerprint Web Server
Whois Lookup
InternetPeriscope
About
My Favorite Links
Resume
View My Profile on LinkedIn
View My Profile on DataCamp
View My Profile on Pluralsight
Back to FDA Applications sponsored by BAYER HEALTHCARE LLC
FDA Drug Application 020641 by BAYER HEALTHCARE LLC
Application Number
020641
Application Type
New Drug Application
Sponsor Applicant
BAYER HEALTHCARE LLC
Most Recent Label Available Flag
Current Patent Flag
Action Type
Approval
Chemical Type
New formulation
Therapeutic Potential
Standard
Orphan Code
Action Type
Duplicate Counter
Action Date
Document Type
Application Document ID
Sequence Number
Document Title
Document URL
Document Date
AP
0
10/10/1996
N
AP
0
1/23/1998
SCM
15931
001
http://www.accessdata.fda.gov/drugsatfda_docs/nda/1998/019670_s008,19658s10,20470s3,20641s120704s3_Claritin-DTOC.cfml
3/2/2007
AP
0
3/30/1998
SLR
AP
0
10/29/1998
SCM
15937
003
http://www.accessdata.fda.gov/drugsatfda_docs/nda/1998/019670_s012,19658s14,20470s7,20641s3,20704s4_ClaritinDTOC.cfml
3/2/2007
AP
0
1/7/1999
SCF
AP
0
12/4/2000
SE5
2478
007
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/20-641S007_Loratadine_Approv.pdf
12/4/2000
AP
0
12/4/2000
SE5
2479
007
http://www.accessdata.fda.gov/drugsatfda_docs/label/2000/20641s7lbl.pdf
12/4/2000
AP
0
12/4/2000
SE5
2480
007
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2000/20-641s007_LoratadineClaritin.cfm
12/4/2000
AP
0
11/27/2002
SE6
2477
009
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2002/19658se6-018,20704se6-008,20641se6-009ltr.pdf
11/27/2002
AP
0
11/27/2002
SE6
10750
009
http://www.accessdata.fda.gov/drugsatfda_docs/nda/2002/19670s18,20470s16,19658s18,20704s8,20641s9_Claritin.cfm
12/7/2004
AP
0
7/23/2002
SCE
AP
0
11/19/2003
SE6
6961
011
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2003/19658se6-020,20704se6-009,20641se6-011ltr.pdf
11/25/2003
AP
0
12/9/2002
SCP
AP
0
7/15/2004
SCP
9773
016
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20641s016ltr.pdf
7/21/2004
AP
0
10/27/2004
SCS
10482
017
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2004/20641s017ltr.pdf
10/29/2004
AP
0
6/14/2005
SCF
11818
018
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/020641s018ltr.pdf
6/15/2005
AP
0
7/25/2008
SCP
20337
024
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/020641s024ltr.pdf
7/30/2008
AP
0
7/25/2008
SLR
20338
025
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2008/020641s025ltr.pdf
7/30/2008
AP
0
11/20/2012
SCM
AP
0
2/28/2013
SCM
35295
032
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/020641Orig1s032ltr.pdf
3/1/2013
AP
0
2/28/2013
SCM
38266
032
http://www.accessdata.fda.gov/drugsatfda_docs/label/2013/020641Orig1s032lbl.pdf
1/14/2014
AP
0
4/16/2013
SCM
AP
0
5/15/2014
SCM
AP
0
4/16/2015
SCM
42595
036
http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020641Orig1s036lbl.pdf
4/21/2015
AP
0
4/16/2015
SCM
42614
036
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020641Orig1s036ltr.pdf
4/22/2015
AP
0
10/21/2015
SCM
44271
037
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020641Orig1s037ltr.pdf
10/23/2015
AP
0
10/21/2015
SCM
44296
037
http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020641s037lbl.pdf
10/26/2015
AP
0
11/5/2015
SLR
44429
038
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020641Orig1s038ltr.pdf
11/9/2015
AP
0
11/5/2015
SLR
44598
038
http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020641Orig1s038lbl.pdf
11/25/2015
AP
0
12/10/2015
SCM
AP
0
12/30/2015
SLR
44920
040
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/020641Orig1s040ltr.pdf
12/31/2015
AP
0
12/30/2015
SLR
44932
040
http://www.accessdata.fda.gov/drugsatfda_docs/label/2015/020641Orig1s040lbl.pdf
1/4/2016
AP
0
2/12/2016
SCM
AP
0
8/9/2016
SLR
46760
042
http://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/020641Orig1s042ltr.pdf
8/10/2016
AP
0
8/9/2016
SLR
46833
042
http://www.accessdata.fda.gov/drugsatfda_docs/label/2016/020641Orig1s042lbl.pdf
8/22/2016
Back to FDA Applications sponsored by BAYER HEALTHCARE LLC